Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

How Dividends Change the Game for Owners of Merck & Co., Inc. (MRK) Stock

The wealth-building power of compound interest will never cease to amaze me. It’s a story of patience and attention to detail, where small, short-term differences add up to massive divergence over decades. And in the end, the biggest winners don’t always deliver the fattest share-price returns.

Merck & Co., Inc. (NYSE:MRK)

Today’s case in point is Merck & Co., Inc. (NYSE:MRK). The pharmaceutical giant’s quarterly dividend payout was stuck at $0.38 per share for many years until it started inching up again in 2012. At the same time, Merck shares went on a long upward run that ended up decreasing your dividend yields despite the higher payouts.

MRK Dividend Chart

MRK Dividend data by YCharts.

So far, this looks like a terrible stock for income investors. Merck & Co., Inc. (NYSE:MRK)’s dividend yield is shrinking, and even the renewed payout growth remains anemic. Why bother?

Here’s why: Merck & Co., Inc. (NYSE:MRK)’s dividend was always generous. It doesn’t take much dividend growth or rising yields to make a big difference when you’re starting from a high base level.

Even now, at the end of the yield-reduction you saw in that last chart, Merck & Co., Inc. (NYSE:MRK) offers the third-richest yield among the 30 dividend-payers of the Dow Jones Industrial Average . At 3.7%, it’s nearly tied for third place with troubled chip titan Intel Corporation (NASDAQ:INTC), whose yield is enriched by the past year’s 9% share-price slide. Investors are worried about the death of the PC and Intel’s limited involvement in the new mobile-computing era.

Merck & Co., Inc. (NYSE:MRK) matches that yield despite a 23% higher share price, which acts as a headwind in this case.

Intel Corporation (NASDAQ:INTC) is a relative newcomer to the high-yield game, but Merck & Co., Inc. (NYSE:MRK) has plenty of shareholder-enriching history behind it. With the highly anticipated Baby Boomer retirement wave on the horizon, I wouldn’t be surprised to see Merck juicing its payouts with rising cash flows in coming years.

Now, back to the long-term patience we talked about earlier. It may be a wise move to lock in your base price today so you can enjoy the potential dividend increases to their full potential later on. To take a historical example, you could have bought Merck & Co., Inc. (NYSE:MRK) shares for $16.34 apiece 10 years ago. That was good for a 3.4% yield at the time — roughly comparable to today’s 3.7% dividend return.

Just sitting on your shares and collecting dividend checks would have given you $15.26 in cash since then — nearly enough to cover the cost of your original shares. The effective yield on your original shares would be a stellar 10.5% right now.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.